Latest filing published 15 Sept 2025 for ZEVRA THERAPEUTICS, INC., €134k.
Filing timeline
BuySaleInsider track record
Closed purchases
Not enough history yet: 1 closed purchase, at least 2 are needed.
Purchases by company
Since each purchase
- +62.5%Entry US$7.26 · Close at T+365 US$11.80
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Alvin Shih: trading record in brief
Alvin Shih discloses dealings in 2 companies, chiefly Travere Therapeutics, Inc. and Zevra Therapeutics, Inc. We count 9 filings; the first trade dates from 26 June 2015 and the latest from 12 September 2025.
On the open market, the record shows 1 purchase worth €134k and 8 sales worth €1.5M. The net balance comes to €1.4M on the selling side. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Since January 2025: 1 purchase and no sales on the market.
The latest filing, published on 15 September 2025, reports an open-market purchase of €134k in Zevra Therapeutics, Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. Section 16 rules allow two business days to file each Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Alvin Shih
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 20,000 shares@ US$7.89100.0% of flowCommon StockSEC:0001610064-25-000011:0Canonical exit: 11 Dec 2025 (T+90)
- 8,750 shares@ US$16.2433.3% of flowCommon StockSEC:0001209191-16-139907:0
- 8,750 shares@ US$17.7536.4% of flowCommon StockSEC:0001209191-16-125331:0
- 8,750 shares@ US$14.3530.3% of flowCommon StockSEC:0001209191-16-104164:0
- 8,750 shares@ US$20.83Common StockSEC:0001209191-15-084554:0
- 4,798 shares@ US$19.58Common StockSEC:0001209191-15-074926:0
- 2,823 shares@ US$20.45Common StockSEC:0001209191-15-074926:1
- 1,129 shares@ US$21.61Common StockSEC:0001209191-15-074926:2
- 27,916 shares@ US$32.70Common StockSEC:0001209191-15-057620:0
9 of 9 declarations
